Dr Ashraf Alkhaldi

Medical oncology

  • is fee assuredFee assured

This healthcare professional let us know that they are currently available for:

    • Face-to-face consultations

Last updated: 12 Nov 2020

Specialises in

  • Breast
  • Colon

About me

Consultant medical oncology who specialist in providing high quality cancer follow up for both women and man with colorectal ca and breast cancer .
Dr.Ash Alkhaldi is the lead of colorectal ca in midyorkshire and consultant oncologist at spire Leeds Hospital .
Dr.Alkhaldi specialises in medical treatment of cancers using the target ,supportive therapies ,chemotherapy and hormone therapy ..
The colorectal cancer drugs like Cetuximab ,Encorafenib + Cetuximab Plus or Minus Binimetinib, Bevacizumab(Avastin).
The Breast ca such as Biphoasphonate and the new target therapy trastuzumab(Herceptin ) Pertuzomab(Prejeta),trastuzumab emtansine(Kadcyla),Everolimus(Afinitor),Lapatinib(Tyvero),Bevacizumab(Avastin) as well CD4/6 inhibitor Palbocicilib,Ribocicilib and abemaciclib.
Modern treatment for Cancer requires the careful integration of diagnostic procedure ,surgical treatment ,and medical therapies with chemotherapy ,target therapies, endocrine therapy and Radiotherapy .
This is brought about through a multidisciplinary team approach where pathologist ,radiologist,surgeons and specialist nurses meet on regular basis to consider the diagnosis and optimal treatment for individual patients.
Dr.Alkhaldi is a member of the multidisciplinary team for colorectal and breast cancer at midyorkshire Trust .

Areas of interest

Medical Oncology; Colo-rectal cancer; Colon cancer; Rectal cancer; Bowel cancer; Lower Gastrointestinal Cancer; Monoclonal Antibodies; Targetted Therapies; Immunotherapy

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (5-50)

    Spire Leeds Hospital (5-50)

Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.